News Classic

Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 17, 2024 (GLOBE NEWSWIRE) — The value of the global closed system transfer devices (CSTD) market sector was estimated at US$ 1.2 billion in 2023. Between 2024 and 2034, it is expected to increase at a CAGR of 10.0%, reaching US$ 3.6 billion.

Public awareness campaigns promoting the risks associated with hazardous medications and the need to handle them with care have resulted in the growing usage of CSTDs. An educational program designed to make healthcare workers aware of the benefits of closed medication preparation and delivery systems should be aimed at healthcare workers.

By preventing contamination during transfer and administration, CSTDs contribute to maintaining pharmaceutical purity and effectiveness. Contamination can lead to serious financial losses or negatively impact patient results regarding expensive or delicate medications.

Request Your PDF Sample Report Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55230

In the medical field, patient safety is of utmost importance. CSTDs help to improve patient safety outcomes during chemotherapy and other drug delivery procedures by reducing the danger of drug exposure and contamination.

The general increase in healthcare spending, especially in industrialized nations, encourages the purchase of technology that enhances patient safety and care. Healthcare facilities must include CSTDs as an essential part of their infrastructure when they budget for safety precautions and regulatory compliance. With biosimilar medications becoming more widely available and being used, CSTDs are necessary for handling these medications.

Competitive Landscape

• ICU Medical
• Baxter
• B. Braun
• BD
• Equashield
• Yukon Medical
• Caragen Ltd.
• JMS Co. Ltd.

Key Findings of the Market Report

• Based on the product, the system segment is expected to drive the closed system transfer devices (CSTD) market.
• In terms of application, the nursing segment will be a major market for the closed system transfer devices (CSTD) market.
• Increasing distributor demand is expected to drive a closed system transfer devices (CSTD) market.
• A dominant position was held by North America in 2023 in the global closed system transfer devices (CSTD) market.

Global Closed System Transfer Devices (CSTD) Market: Growth Drivers

• The adoption of CSTDs is fueled by tightening requirements imposed by regulatory organizations, including the European Medicines Agency (EMA), US Pharmacopeia (USP), and the Occupational Safety and Health Administration (OSHA) regulating the handling of dangerous medications. To comply with these rules, patients and healthcare professionals must be protected from exposure to closed systems.
• Increasing global cancer incidence is causing doctors to use chemotherapy medications more frequently, which are often dangerous and must be handled carefully. A safer method of administering these medications is through CSTDs, which pose less risk of contamination and exposure for healthcare workers.
• A growing focus on protecting healthcare personnel from occupational dangers is driving healthcare institutions to invest in technology that improves workplace safety.
• A CSTD is considered to be an essential component of ensuring the safety of workers who are responsible for preparing and administering dangerous medications.
• Standards and safety measures are in greater demand as the global healthcare infrastructure grows, particularly in emerging nations. Using technologies such as CSTDs is one way of ensuring compliance with global safety standards.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55230

Global Closed System Transfer Devices (CSTD) Market: Regional Landscape

• North America is expected to drive the demand for CSTD in the coming years. North America, especially the United States and Canada, has some of the most stringent restrictions for handling dangerous medications. According to the US Pharmacopeia (USP) and the US Occupational Safety and Health Administration (OSHA), strict regulations protect healthcare professionals from hazardous material exposure.
• Due to the increasing rate of cancer in North America, there is a need for safe handling procedures as well as chemotherapy medications. In particular, the United States suffers from a considerable cancer burden that is primarily treated by chemotherapy. Therefore, CSTDs, which ensure safe medication administration, have a thriving market.
• Healthcare personnel in North America are strongly encouraged to prevent occupational hazards. Hospitals and other healthcare facilities prioritize worker safety over anything else, so they invest in tools like CSTDs to minimize the risk of exposure to dangerous medications.
• Modern clinics, hospitals, and specialty treatment facilities are all part of North America’s sophisticated healthcare network. As part of their regular practices, these hospitals are more likely to incorporate cutting-edge technologies, such as CSTDs, to enhance patient care and safety.

Global Closed System Transfer Devices (CSTD) Market: Key Players

Closed system transfer devices (CSTD) manufacturers invest heavily in research and development to improve their products. To increase their product portfolio and meet the demand from expanding healthcare facilities, closed system transfer devices (CSTD) companies have to leverage strategic collaborations, mergers, and acquisitions.

Key Developments

• In October 2023, EQUASHIELD, the industry leader in Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that its EQUASHIELD® Syringe Unit has been cleared for full volume use by the FDA.
• Syringe units with closed plungers are designed to prevent deliberate and unintentional syringe plunger detachment and to allow the use of hazardous drugs up to the maximum nominal volume of the system.

Global Closed System Transfer Devices (CSTD) Market: Segmentation

By Product

• Needle-free Systems
• Needle Systems

• Vial Adaptors
• Syringe Adaptors
• Tubing Sets and Accessories

By Application

• Pharmacy
• Nursing
• Veterinary

By Distribution Channel

By Region

• North America
• Latin America
• Asia Pacific
• Europe
• Middle East & Africa

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights! https://www.transparencymarketresearch.com/checkout.php?rep_id=55230&ltype=S

Explore wide-ranging Coverage of TMR’s Healthcare Market Insights Landscape

• Influenza Diagnostics Market – The global influenza diagnostics market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for influenza diagnostics is estimated to reach US$ 2.0 billion by the end of 2031.
• Sharps Containers Market – The sharp containers accounted for US$ 701.1 million in 2022. A CAGR of 4.7% is projected from 2023 to 2031. The market is expected to reach US$ 1.0 billion by 2031. Developing economies generate more medical waste, particularly as their healthcare infrastructure expands. Healthcare facilities are increasingly relying on sharp containers as a safe and effective way to dispose of waste.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

MCLEAN, Va., Oct. 17, 2024 (GLOBE NEWSWIRE) — Freddie Mac FMCC today released the results of its Primary Mortgage Market Survey^® (PMMS^®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.44 percent.

“The 30-year fixed-rate mortgage increased for the third consecutive week, moving closer to 6.5%,” said Sam Khater, Freddie Mac’s Chief Economist. “In general, higher rates reflect the strength in the economy that is supportive of the housing market. But notably, as compared to a year ago, rates are more than one percentage point lower and potential homebuyers can stand to benefit, especially by shopping around for the best quote as rates can vary widely between mortgage lenders.”

News Facts

• The 30-year FRM averaged 6.44 percent as of October 17, 2024, up from last week when it averaged 6.32 percent. A year ago at this time, the 30-year FRM averaged 7.63 percent.
• The 15-year FRM averaged 5.63 percent, up from last week when it averaged 5.41 percent. A year ago at this time, the 15-year FRM averaged 6.92 percent.

The PMMS^® is focused on conventional, conforming, fully amortizing home purchase loans for borrowers who put 20 percent down and have excellent credit. For more information, view our Frequently Asked Questions.

Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout all economic cycles. Since 1970, we have helped tens of millions of families buy, rent or keep their home. Learn More: Website | Consumers | X | LinkedIn | Facebook | Instagram | YouTube

MEDIA CONTACT:
Angela Waugaman
(703)714-0644
Angela_Waugaman@FreddieMac.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1c0b88be-40a6-4f31-8bc9-41be51faecc3

A sharp rise in September retail sales is sparking fresh debate among economists about the Federal Reserve’s next move, as stronger-than-expected consumer resilience raises doubts about the need for further interest rate cuts.

Retail sales rose 0.4% month-over-month in the last month of the quarter, far exceeding the 0.1% growth recorded in August and surpassing economists’ forecasts of 0.3%. Even more notably, excluding volatile sectors like autos and gasoline, sales surged by 0.7%, marking the second-largest increase over the past 12 months.

The stronger-than-expected sales report is pushing analysts to rethink whether the Federal Reserve will move forward with another interest rate cut in November. While market participants overwhelmingly anticipate a 25 basis point reduction following the 50-basis-point move last month, the latest economic data may complicate that outlook.

Economists Debate On Fed Interest Rates

Quincy Krosby, chief global strategist at LPL Financial, said, “Retail sales came in well above expectations and continue to defy the weak economy thesis.”

Krosby added that the key question for monetary policy is whether the Fed will be concerned that the economy’s renewed strength could drive inflation higher.

However, she expects that a 25-basis-point cut will occur, especially if hurricane damage significantly impacts the labor market.

Speaking to CNBC, Stifel chief economist Lindsey Piegza said, “I think this was a very strong number and underscores the notion that the Fed maybe took too big of a step out of the gate with that 50 basis point cut.” Looking ahead, Piegza explained that there’s a stronger argument for a more patient approach, potentially holding off on a November cut.

Kathy Bostjancic, chief economist at Nationwide, also commented on the retail data: “That’s positive, right, for the overall economy. It’s really big consumer spending buoying the overall GDP growth in the US.”

Regarding the next Fed moves, Bostjancic added that “it’s not a slam dunk that they will cut rates.”

LPL Financial’s chief economist Jeffrey Roach maintains that the Fed will proceed with gradual cuts.

“Strong consumer spending in September suggests economic growth in the previous quarter was solidly above trend. Looking ahead, investors need to monitor any signs that the unemployed are finding it more difficult to earn a paycheck. Our baseline remains that the Fed will likely cut a quarter of a percent in both November and December.” Roach said.

Investors still largely anticipate a cut at the upcoming Fed meeting. Market-implied odds of a 25-basis-point rate cut in November dipped only slightly from 94% to 87% on Thursday.

Market Reactions: Treasury Yields Rise, Gold Hits Record Highs

Stronger-than-expected retail sales data, combined with a drop in unemployment claims, sparked a sharp rise in Treasury yields on Thursday, putting the brakes on further stock market gains.

The yield on the 10-year Treasury jumped 8 basis points to 4.10%, while the 30-year yield surged 9 basis points to 4.39%. This spike in yields hit Treasury-related assets hard, with the iShares 20+ Year Treasury Bond ETF TLT tumbling 1.5%. The surge in Treasury yields weighed on investor risk sentiment.

After opening 0.6% higher to fresh record highs, the S&P 500 was up just 0.3% by 12:15 p.m. in New York. The tech-heavy Nasdaq 100, tracked by the Invesco QQQ Trust QQQ, which had risen over 1% at the open, was up 0.7% at the time of publication.

Meanwhile, gold prices, as tracked by the SPDR Gold Trust GLD, rose 0.7%, hitting new all-time highs.

Read Next:

Image created using artificial intelligence via Midjourney.

Investors with a lot of money to spend have taken a bearish stance on Calumet CLMT.

And retail traders should know.

We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don’t know. But when something this big happens with CLMT, it often means somebody knows something is about to happen.

Today, Benzinga’s options scanner spotted 14 options trades for Calumet.

This isn’t normal.

The overall sentiment of these big-money traders is split between 28% bullish and 50%, bearish.

Out of all of the options we uncovered, there was 1 put, for a total amount of $40,200, and 13, calls, for a total amount of $1,144,494.

What’s The Price Target?

After evaluating the trading volumes and Open Interest, it’s evident that the major market movers are focusing on a price band between $13.0 and $40.0 for Calumet, spanning the last three months.

Analyzing Volume & Open Interest

In terms of liquidity and interest, the mean open interest for Calumet options trades today is 4198.58 with a total volume of 5,404.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Calumet’s big money trades within a strike price range of $13.0 to $40.0 over the last 30 days.

Calumet Option Volume And Open Interest Over Last 30 Days

Significant Options Trades Detected:

About Calumet

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.

After a thorough review of the options trading surrounding Calumet, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Where Is Calumet Standing Right Now?

• With a volume of 1,520,256, the price of CLMT is up 15.37% at $25.3.
• RSI indicators hint that the underlying stock may be overbought.
• Next earnings are expected to be released in 21 days.

What The Experts Say On Calumet

A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $25.0.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $25.
* In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $25.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Calumet options trades with real-time alerts from Benzinga Pro.

Bank of America released a bullish note on gold Thursday, just as the precious metal reached new record highs at $2,696 per ounce (oz).

Gold remains “the ultimate perceived safe haven asset” in today’s macroeconomic environment, according to Bank of America’s commodity analyst Michael Widmer, amid rising concerns over U.S. fiscal policies and their potential impact on Treasury yields.

Gold Trends Higher As Fed Shifts Policy

Despite nominal U.S. Treasury yields trending upward, gold prices, as tracked by the SPDR Gold Trust GLD, have been climbing in recent weeks, supported by various factors.

Widmer explained that a key driver behind this surge is the rising inflation expectations paired with the Federal Reserve’s policy shifts.

Rate cuts triggered a surge in inflation expectations, which in turn kept downward pressure on real yields, increasing gold’s appeal as an inflation hedge.

“Accompanying the first Fed’s 50bp rate cut, inflation expectations have risen, meaning that 10-year real yields, usually the most significant gold price driver, kept declining through September,” Widmer said.

Gold Hits All-Time Highs On Oct. 17

U.S. Fiscal Policy Boosts Bullish Gold Outlook

A key factor bolstering Bank of America’s bullish stance on gold is the U.S.’s fiscal trajectory.

Rising interest rates have significantly increased the federal government’s debt servicing costs, triggering concerns about fiscal sustainability. According to government projections, the national debt is projected to reach a new record high as a share of the U.S. economy within the next three years.

Widmer highlighted that “whoever wins the 2024 presidential election will face an unprecedented fiscal situation upon taking office. Neither Kamala Harris nor Donald Trump seems to prioritize fiscal consolidation.”

The CRFB report details that Vice President Harris’s proposed policies could increase the national debt by $3.5 trillion through 2035, while former President Trump’s platform might raise it by as much as $7.5 trillion. “

The large and growing national debt threatens to “to slow economic growth, boost interest rates and payments, weaken national security, constrain policy choices, and raise the risk of an eventual fiscal crisis.” 

Global Trends Also Favor Gold

According to Widmer, fiscal expansion policies are gaining traction across advanced economies, contributing to gold’s global appeal. The International Monetary Fund (IMF) estimates that new fiscal spending related to climate adaptation, demographic shifts, and rising defense costs could amount to 7-8% of global GDP annually by 2030.

This massive spending will likely force governments to issue more debt, and as volatility in the bond markets rises, gold will emerge as a refuge for investors, Widmer explained.

Central banks are also anticipated to increase their gold holdings as part of currency reserve diversification. The share of global central bank reserves held in gold has climbed to 10%, up from just 3% a decade ago.

Outlook for Gold: $3,000/oz By 2025

Bank of America sees gold reaching the $3,000/oz mark by the first half of 2025. The combination of macroeconomic uncertainty, rising debt levels, and central bank buying makes gold the “last safe haven asset standing.”

Read Next:

Photo: Shutterstock